Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acceptance and Commitment Therapy | 3 | 2025 | 12 | 2.030 |
Why?
|
| Chronic Pain | 4 | 2025 | 154 | 1.930 |
Why?
|
| Pain Management | 4 | 2025 | 161 | 1.840 |
Why?
|
| Veterans | 10 | 2025 | 765 | 1.480 |
Why?
|
| Psychiatry | 1 | 2025 | 126 | 0.820 |
Why?
|
| Self-Management | 2 | 2025 | 62 | 0.440 |
Why?
|
| Social Support | 3 | 2025 | 371 | 0.430 |
Why?
|
| Opioid-Related Disorders | 3 | 2025 | 507 | 0.330 |
Why?
|
| Community Integration | 3 | 2018 | 7 | 0.330 |
Why?
|
| United States Department of Veterans Affairs | 5 | 2025 | 544 | 0.240 |
Why?
|
| Equivalence Trials as Topic | 1 | 2025 | 14 | 0.240 |
Why?
|
| Adult | 12 | 2025 | 16794 | 0.240 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2005 | 94 | 0.230 |
Why?
|
| Acute Pain | 1 | 2025 | 21 | 0.230 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2020 | 397 | 0.220 |
Why?
|
| Employment | 1 | 2025 | 127 | 0.220 |
Why?
|
| Humans | 21 | 2025 | 63309 | 0.220 |
Why?
|
| Pain Measurement | 1 | 2025 | 345 | 0.210 |
Why?
|
| Pilot Projects | 2 | 2024 | 1007 | 0.200 |
Why?
|
| Tobacco Use Cessation | 1 | 2022 | 29 | 0.200 |
Why?
|
| Feasibility Studies | 1 | 2024 | 568 | 0.190 |
Why?
|
| Analgesics, Opioid | 2 | 2025 | 536 | 0.180 |
Why?
|
| Male | 12 | 2025 | 29834 | 0.180 |
Why?
|
| Internet | 1 | 2025 | 469 | 0.180 |
Why?
|
| Transgender Persons | 1 | 2022 | 69 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 769 | 0.180 |
Why?
|
| Sexual and Gender Minorities | 1 | 2022 | 76 | 0.180 |
Why?
|
| Health Services Accessibility | 2 | 2025 | 564 | 0.180 |
Why?
|
| Naltrexone | 2 | 2021 | 89 | 0.170 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 2569 | 0.170 |
Why?
|
| Buprenorphine | 2 | 2021 | 192 | 0.170 |
Why?
|
| Mental Disorders | 2 | 2025 | 792 | 0.170 |
Why?
|
| Reproducibility of Results | 1 | 2025 | 1650 | 0.170 |
Why?
|
| Female | 11 | 2025 | 32806 | 0.170 |
Why?
|
| Mental Health | 2 | 2023 | 371 | 0.160 |
Why?
|
| Narcotic Antagonists | 2 | 2021 | 136 | 0.160 |
Why?
|
| Pandemics | 1 | 2023 | 672 | 0.140 |
Why?
|
| Robotics | 1 | 2019 | 87 | 0.140 |
Why?
|
| Rehabilitation, Vocational | 1 | 2018 | 32 | 0.140 |
Why?
|
| Quality of Life | 1 | 2025 | 1225 | 0.140 |
Why?
|
| Self-Help Groups | 1 | 2018 | 37 | 0.140 |
Why?
|
| Employment, Supported | 1 | 2018 | 21 | 0.140 |
Why?
|
| Middle Aged | 9 | 2025 | 17558 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2025 | 733 | 0.140 |
Why?
|
| Education | 1 | 2018 | 68 | 0.140 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 2674 | 0.130 |
Why?
|
| United States | 10 | 2025 | 7827 | 0.130 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 2005 | 68 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2025 | 5660 | 0.130 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 265 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 1100 | 0.120 |
Why?
|
| Ambulatory Care | 3 | 2005 | 311 | 0.110 |
Why?
|
| Aged | 6 | 2024 | 14396 | 0.110 |
Why?
|
| Injections, Intramuscular | 2 | 2021 | 71 | 0.080 |
Why?
|
| Veterans Health | 2 | 2024 | 158 | 0.080 |
Why?
|
| HIV Infections | 3 | 2005 | 968 | 0.080 |
Why?
|
| Hospitalization | 2 | 2005 | 1359 | 0.070 |
Why?
|
| Young Adult | 3 | 2022 | 4687 | 0.060 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2005 | 8 | 0.060 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2005 | 19 | 0.060 |
Why?
|
| Self-Control | 1 | 2025 | 9 | 0.060 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2025 | 86 | 0.060 |
Why?
|
| Health Resources | 1 | 2005 | 94 | 0.060 |
Why?
|
| Hospitals, Military | 1 | 2023 | 4 | 0.050 |
Why?
|
| Behavior Therapy | 1 | 2025 | 167 | 0.050 |
Why?
|
| Exercise Therapy | 1 | 2024 | 104 | 0.050 |
Why?
|
| Multivariate Analysis | 4 | 2005 | 936 | 0.050 |
Why?
|
| Opiate Substitution Treatment | 1 | 2025 | 206 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 6638 | 0.050 |
Why?
|
| Buprenorphine, Naloxone Drug Combination | 1 | 2021 | 26 | 0.040 |
Why?
|
| Confidence Intervals | 3 | 2005 | 240 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2021 | 114 | 0.040 |
Why?
|
| Caregivers | 1 | 2024 | 271 | 0.040 |
Why?
|
| Mental Health Services | 1 | 2023 | 287 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2005 | 768 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2005 | 2569 | 0.040 |
Why?
|
| Mobile Applications | 1 | 2019 | 136 | 0.030 |
Why?
|
| Peer Group | 1 | 2018 | 105 | 0.030 |
Why?
|
| Workplace | 1 | 2018 | 172 | 0.030 |
Why?
|
| Methadone | 1 | 2017 | 134 | 0.030 |
Why?
|
| Family | 1 | 2018 | 238 | 0.030 |
Why?
|
| Counseling | 1 | 2018 | 362 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2005 | 5449 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 1123 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3285 | 0.030 |
Why?
|
| Patient Admission | 2 | 2005 | 197 | 0.030 |
Why?
|
| Length of Stay | 2 | 2005 | 811 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2005 | 53 | 0.020 |
Why?
|
| Medical Records | 1 | 2005 | 137 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 253 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2005 | 70 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2005 | 286 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2005 | 136 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 209 | 0.010 |
Why?
|
| Poverty | 1 | 2005 | 296 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2005 | 203 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 777 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 1274 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2005 | 690 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 5345 | 0.010 |
Why?
|
| Adolescent | 1 | 2005 | 6247 | 0.010 |
Why?
|